CSF1R and glioblastoma: The high-risk GBM patients’ group showed a significantly elevated StromalScore, ImmuneScore, and ESTIMATEScore, and also overexpressed immune checkpoint molecules such as PDCD1, HAVCR2, and CSF1R, pointing to an environment shaped by immunosuppressive signals [47].